Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/14ROCHE HOLDINGS AG : Receives a Buy rating from JP Morgan
MD
09/14GILEAD SCIENCES : Immunomedics Shares More Than Double After Gilead Deal
DJ
09/14BIOGEN : to Invest $250 Million in 20-Year Climate-Change Plan
DJ
09/14Regeneron's antibody drug added to UK Recovery trial of COVID treatments
RE
09/14BAYER AG : Deutsche Bank reaffirms its Buy rating
MD
09/14NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
09/14Merck to buy $1 bln stake in Seattle Genetics, co-develop cancer therapy
RE
09/14GLOBAL MARKETS -Vaccine hopes lift world stocks, but caution creeps in
RE
09/14NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
09/14MERCK : to Invest $1 Billion in Seattle Genetics, Collaborate on Breast-Cancer Treatment
DJ
09/14Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study
RE
09/14ASTRAZENECA : UK COVID-19 vaccine trials restarted, EU medical register shows
RE
09/14Regeneron's antibody drug added to UK Recovery trial of COVID treatments
RE
09/14ELI LILLY AND : Incyte Find Covid-19 Treatment Reduces Hospital Time
DJ
09/14GILEAD SCIENCES : Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-19 patients
RE
Discover
09/14MERCK KGAA : Morgan Stanley remains Neutral
MD
09/14Gilead bolsters cancer portfolio with $21 bln acquisition of Immunomedics
RE
09/14BAYER AG : Morgan Stanley keeps its Buy rating
MD
09/14European healthcare stocks hit by Trump drug order
RE
09/14KONINKLIJKE PHILIPS N : Philips Targets 25% Revenues From Reused, Recycled Products By 2025
DJ
09/14AstraZeneca shares gain as coronavirus vaccine trials resume
RE
09/14Shares rise on vaccine hopes; Turkish lira skids on Moody's downgrade
RE
09/14Vaccine hopes boost world share markets
RE
09/14GREEN CROSS : Asia offers more flu shots to head off COVID-19 complications
RE
09/14ASTRAZENECA : London stocks gain as AstraZeneca resumes vaccine trials
RE
09/14ASTRAZENECA : shares rise as UK coronavirus vaccine trial resumes
RE
09/14Gilead Acquires Cancer-Drug Maker -- WSJ
DJ
09/14AstraZeneca Resumes U.K. Vaccine Trials -- WSJ
DJ
09/14Asian shares buoyed by coronavirus vaccine hopes
RE
09/14DYNAVAX TECHNOLOGIES : Valneva to supply up to 190 million doses of COVID-19 vaccine to UK
RE
09/14MOLECULAR PARTNERS : completes manufacturing runs in bid for COVID-19 drug
RE
09/13Gilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th Update
DJ
09/13Gilead Reaches Deal to Buy Immunomedics for $21 Billion--4th Update
DJ
09/13AstraZeneca Covid-19 Vaccine Trials Resume in U.K.--2nd Update
DJ
09/13GILEAD SCIENCES : nears deal to buy Immunomedics for more than $20 billion - WSJ
RE
09/13AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
RE
09/13AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
RE
09/12GILEAD SCIENCES : Nears Deal to Buy Immunomedics for More Than $20 Billion
DJ
09/12AstraZeneca Covid-19 Vaccine Trials Resume in U.K.--2nd Update
DJ
09/12Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd Update
DJ
09/12GILEAD SCIENCES : Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd Update
DJ
09/12GILEAD SCIENCES : Nears Deal to Buy Immunomedics for More Than $20 Billion--Update
DJ
09/12AstraZeneca Covid-19 Vaccine Trials Resume in U.K.--2nd Update
DJ
09/12AstraZeneca Covid-19 Vaccine Trials Resume in U.K.--Update
DJ
09/12ASTRAZENECA : Covid-19 Vaccine Trials Resume in the U.K.
DJ
09/12WHAT'S NEWS : Business & Finance -- WSJ
DJ
09/11Merck starts recruitment for COVID-19 vaccine trial
RE
09/11ASTRAZENECA : DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine - ANI
RE
09/11GILEAD SCIENCES : U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients
RE
09/11Merck Covid-19 Vaccine Begins Human Testing--Update
DJ
09/11SPECIAL REPORT : Big Pharma wages stealth war on drug price watchdog
RE
09/11ELI LILLY AND : Migraine Drug Achieves Positive Phase 3 Results
DJ
09/11BAYER AG : Warburg Research reiterates its Neutral rating
MD
09/11Year-End Still Target For Oxford Drug Data -- WSJ
DJ
09/10Australia shares hit over 2-month low as tensions with China mount
RE
09/10INTUITIVE SURGICAL : Autonomous Robots Are Coming to the Operating Room
DJ
09/10BAYER : CEO's term extended, makes progress on Roundup settlement
RE
09/10ASTRAZENECA : vaccine trial pause a 'wake-up call', says WHO
RE
09/10AstraZeneca expects COVID vaccine result by year-end if trials resume
RE
09/10ASTRAZENECA : New Coronavirus Cases Rise in U.S. Despite Slowdown in Testing -- Update
DJ
09/10ASTRAZENECA : New Coronavirus Cases Rise in U.S. Despite Slowdown in Testing
DJ
09/10ASTRAZENECA : Serum Institute pauses India trials of AstraZeneca's COVID-19 vaccine
RE
09/10AstraZeneca CEO Sees Oxford Vaccine Possible by End of Year, Despite Setback
DJ
09/10AstraZeneca CEO Still Sees Oxford Vaccine Possible By End of Year
DJ
09/10Several Covid-19 Vaccines Could Join Winner's Circle
DJ
Discover
09/10ASTRAZENECA : JP Morgan reaffirms its Buy rating
MD
09/10ASTRAZENECA : asthma drug succeeds late-stage study
RE
09/10WHAT'S NEWS : World-Wide
DJ
09/10ASTRAZENECA : Panel Probes Interruption of Vaccine Study
DJ
09/10ASTRAZENECA : Fasenra Met Co-Primary Endpoints in OSTRO Phase 3 Trial
DJ
Prev.1  2   3  4  5  6  7  8  9  10Next